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Chronic Effects of Lead on the
Renin-Angiotensin System
by Arthur J. Vander*
This paper reviews the chronic effects of lead exposure on the renin-angiotensin system in
experimental animals and human beings. In rats, when lead exposure is begun several weeks after
birth in doses that cause blood lead concentrations (PbB) of 30 to 40 pg/dL, the result is an increase
in basal plasma renin activity (PRA) and renal renin concentration, with no change in the metabolic
clearance ofrenin; this is presumptive evidence for increased renin secretion. PRA is also increased in
1-month-old animals whose exposure to lead (in doses that raise PbB to 9 pg/dL) was begun in utero.
In contrast, older animals whose exposure was begun in utero manifest no change or a decrease in
their PRA and renal renin concentration. Regardless ofwhen the exposure is begun, lead can decrease
the plasma concentration of angiotensin II at any given PRA, but the dose required for this effect is
highly variable. The hypertension induced by lead exposure is associated with low PRA and a normal
angiotensin IJ/PRA ratio. Chronic human exposure to lead also is associated with highly variable
changes in PRA from study to study; it has been reported to be decreased under both basal and
stimulated conditions, unchanged, or increased in a manner exponentially related to PbB. The human
data are consistent with the tentative hypothesis that lead-exposed persons may have higher PRA than
normal during the early periods of modest exposure but normal or depressed PRA following more
chronic severe exposures. In a small preliminary study, blood lead concentration was found to be
higher in high-renin hypertensive persons than in normotensive persons.
Introduction
Since the renin-angiotensin system is one of the
most potent pressor systems in the body, lead-induced
changes in the system might well influence arterial
blood pressure. Our laboratory has extensively studied
the effects of both acute and chronic lead exposure on
this system in experimental animals, but the present
review of those experiments will be restricted to the
chronic studies, as these are most relevant to the issue
of whether lead exerts a chronic influence on human
blood pressure. The second part ofthis paper will review
the existing data relating lead exposure and the renin-
angiotensin system in humans.
Animal Studies
Renin
Table 1 is a summary (1) of published animal
studies performed in our laboratory relating chronic
lead exposure to plasma renin activity (PRA) or to
plasma renin concentration. Typical results from these
experiments are illustrated in Figures 1-8.
Figure 1 is an example ofthe effects oflead on plasma
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renin concentration (PRC) in rats, using the simplest
protocol: exposure of the animals to 500 ppm lead in
drinking water beginning at 5 weeks of age and
continuing for 4 to 5 months. The basic and replicable
finding in this type of exposure is a lead-induced in-
crease in PRA or PRC of approximately 50% (2,3).
[PRA and PRC may be taken as equivalent measures
in all these experiments, because lead exposure does not
cause a dissociation between these two methods for
evaluating plasma renin (2).1
Figure 2 shows that renal renin concentration is
also elevated to the same degree as plasma renin (2,3).
This constitutes strong indirect evidence that in-
creased renin secretion is the cause of the increased
plasma renin, as renal renin concentration and renin
secretion are known to vary in the same direction in a
wide variety of situations. This conclusion-that an
increase in renin secretion, not a decrease in renin re-
moval from the plasma was the cause of the increased
plasma renin-was confirmed by our finding that the
metabolic clearance of renin is unchanged during
this type of chronic exposure (2). [In contrast, lead-
induced changes in metabolic clearance importantly
influence plasma renin in acute studies (4).]
Figure 3 presents an experiment similar to that
shown in Figure 1; however, in addition to studying
basal PRA, renin secretion was experimentally stimu-A. J. VANDER
Table 1. Summary ofanimal studies relating chronic lead exposure and plasma renin activity.a
Effecton Effecton
Age Duration basal PRAb provoked PRA
Sex, Pb exposure, PbB, exposure of relative relative
Reference species n ppm pg/dL begun exposure to control to control AII/PRA
(3) M rat 6 0
M rat 6 500 30.0 5 weeks 5 months Increased Blunted
(6) M rat 10 0 1.4
M rat 10 5 5.6 In utero 5 months NSC NS NS
M rat 5 25 18.2 In utero 5 months Decreased Increased Decreased
(7) Mrat 13 0 2.2
M rat 16 100 40.4 In utero 6 months Decreased NS NS
M rat 10 500 70.8 In utero 6months NS NS Decreased
(5) Frat 22 0 2.8
F rat 23 5 9.0 In utero 1 month Increased
F rat 20 25 18.6 In utero 1 month Increased
M rat 12 0
M rat 13 100 32.6 In utero 1 month Increased -
M rat 13 500 65.8 In utero 1 month Increased
Frat 6 0
F rat 19 100 30.0 In utero 1 month NS Blunted NS
F rat 13 500 78.2 In utero 1 month Increased NS Decreased
(2) M rat 30 0 2.2
M rat 18 500 41.3 5 weeks 4 months Increased NS
M rat 12 1000 54.9 5 weeks 4 months Increased Decreased
(8) M rabbit 5 0 7 2 months 7 weeks
M rabbit 7 500 66 2 months 7 weeks NS
M rabbit 5 1000 109 2 months 7 weeks NS
aAdapted from Sharp et al. (1).
bPRA, plasma renin activity.
CNS, not significant.
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FIGURE 1. Effect of chronic lead exposure (500 ppm in the drinking
water) on basal plasma renin concentration in rats. Exposure was
begun when the rats were 5 weeks old, and blood samples were
obtained by decapitation 4 months later. Asterisk denotes p value
of < 0.05. The PbB in the lead-exposed animals averaged 41.3
,g/dL. Figure originally published in Keiser et al. (2).
500
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FIGuRE 2. Effect of chronic lead exposure (500 ppm in the drinking
water) on renal renin concentration in rats. These measurements
are from the same animals whose PRA values are shown in Fig. 1.
Asterisk denotes p value of < 0.05. Figure originally published in
Keiser etal. (2).
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FIGURE 3. Effects of chronic lead exposure (500 ppm in the drinking
water) on plasma renin activity (PRA) in rats on standard low
sodium rat chows. Exposure was begun when the rats were 5
weeks old and blood samples were obtained 5 months later.
Asterisk denotes p value of < 0.02. The PbB in the lead-exposed
animals averaged 30.0 pg/dL. Data are from Fleischer et al. (3).
lated in two groups of animals by placing them on a
low sodium diet (3). Under such conditions, although
basal PRA (i.e., PRA in the animals on the usual rat
diet) was elevated in the lead-exposed animals, there
was no significant difference in PRA between the
unexposed and exposed animals on the low sodium
diet. Thus, lead exposure appeared to blunt the renin
response to the stimulus of a low sodium diet.
The next sets ofexperiments involved exposure of the
animals to lead in utero, followed by continued expo-
sure after birth for the remainder of the experiment.
We used this model to mimic more closely human
exposures to lead. Figures 4 and 5 illustrate the effects of
this type of exposure on PRA at 1 month after birth (5).
As expected from the studies previously described, the
lead-exposed animals showed a significant elevation of
PRA; indeed, as shown in Figure 5, a significant in-
crease in PRA was seen with an exposure ofonly 5 ppm.
(Also consistent with the studies described above, the
increase in PRA in response to the stimulus of anes-
thesia and laparotomy was significantly less than that
of the control animals.)
However, as illustrated in Figures 6 and 7, a reversal
of this pattern was seen when animals subjected to this
exposure protocol were studied at 5 to 6 months of age,
the exposure having been continued throughout
(6,7). Instead of a significant increase in PRA, animals
exposed to the middle range of lead doses (25 ppm and
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FIGURE 4. Effects of lead exposure, begun in utero, on plasma renin
activity in rats at 1 month of age. The pregnant mothers were given
100 or 500 ppm lead in the drinking water throughout pregnancy
and lactation, and the offspring were given the same dose following
weaning and continuing for 1 month. The PbB in the lead-exposed
animals averaged 32.6 pg/dL in the 100-ppm group and 65.8 pg/dL
in the 500-ppm group. Figure originally published in Victery et al.
(5).
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FIGURE 5. Effects of lead exposure, begun in utero, on plasma renin
activity in rats at 1 month ofage. The pregnant mothers were given
5 or 25 ppm lead in the drinking water throughout pregnancy and
lactation, and the offspring were given the same dose following
weaning and continuing for 1 month. The PbB in the lead-exposed
animals averaged 9.0 Vg/dL in the 5-ppm group and 18.6 Vg/dL in
the 25-ppm group. Figure originally published in Victery et al. (5).
100 ppm) showed significant reductions in PRA. Doses
of 5 ppm and 500 ppm had no effect on PRA. Renal
renin concentrations paralleled the changes in PRA,
indicating that the decreases in PRA were due to
decreases in renin secretion.
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FIGuRE 6. Effects of lead exposure, begun in utero, on plasma renin
activity in rats at 5 months of age. The pregnant mothers were
given 5 or 25 ppm lead in the drinking water throughout the
pregnancy and lactation, and the offspring were given the same
dose following weaning and continuing for 1 month. The PbB in the
lead-exposed animals averaged 5.6 pg/dL in the 5-ppm group and
18.2 pg/dL in the 25-ppm group. Figure originally published in
Victery et al. (6).
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FIGURE 7. Effects of lead exposure, begun in utero, on plasma renin
activity in rats at 6 months of age. The pregnant mothers were
given 100 or 500 ppm lead in the drinking water throughout
pregnancy and lactation, and the offspring were given the same
dose following weaning and continuing for 1 month. The PbB in the
lead-exposed animals averaged 40.4 pg/dL in the 100-ppm group
and 70.8 pg/dL in the 500-ppm group. Asterisk denotes p value of <
0.01. Data from Victery et al. (7).
The final animal experiment was performed in rab-
bits rather than in rats (8). Exposure to lead (500 and
1000 ppm) was begun at 2 months of age and
continued for 7 weeks. PRA was not different in the
exposed rabbits, but kidney slices from exposed groups
secreted significantly more renin in vitro compared to
controls; interestingly, the responsiveness of the slices
to a ,-adrenergic stimulus was significantly lower in
the 1000 ppm group.
The generalization that emerges from these animal
studies is that the chronic effects of lead on renin
secretion vary over the entire spectrum from stimu-
lation to inhibition, depending not only on dose, but
on the time the exposure is begun, the length of
exposure, and the physiological state of the animal (for
example, whether sodium depleted). The ability of lead
either to increase or decrease renin secretion is not
surprising in light of the present knowledge of cellular
mechanisms controlling renin secretion (9). It is
thought that renin secretion is inversely related to the
cytosolic calcium concentration of the renin-secreting
cells (the granular cells of the juxtaglomerular appa-
ratus). By influencing different pathways of calcium
metabolism in the granular cell under different ex-
perimental conditions, lead could either increase cyto-
solic calcium (thereby decreasing renin secretion) or
decrease it (thereby increasing renin secretion).
Angiotensin II
This review has dealt thus far only with renin, but
it is angiotensin II (AII), not renin, that is the vaso-
pressor agent in the renin-angiotensin system (acting
both directly on vascular smooth muscle and in-
directly by facilitating the activity of the sympathetic
nervous system). Normally, since renin is rate-limit-
ing for the generation of AII, there is a linear relation-
ship between plasma renin concentration and AII, as
shown in Figure 8 (5). This figure also shows that the
relationship is not altered by chronic exposure to 100
ppm lead, but that the slope is decreased in animals
exposed to 500 ppm, i.e., at any given PRA, plasma AII is
lower than normal.
A convenient way of expressing this relationship
between renin and AII is as an AII/PRA ratio. The
minimal dose of lead required to reduce this ratio sig-
nificantly varied considerably (from 25 to 1000 ppm)
from experiment to experiment (Table 1). Neither
angiotensinogen nor the ability of renin to catalyze
the generation of angiotensin I (AI) is influenced by
lead exposure (3); therefore, a likely cause ofthe ability
of lead to reduce plasma AII at any given PRA is inhi-
bition of angiotensin converting enzyme, the zinc-
containing enzyme that converts AI to AII. However,
although we have shown (unpublished observations)
that acute administration of lead to experimental
animals does partially inhibit the pulmonary con-
version of AI to All (as well as increase the metabolic
clearance of plasma AII), we have not been able to
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FIGURE 8. Linear regression of AII on PRA for 1-month-old rats
subjected to pentobarbital anesthesia and laparotomy to increase
plasma AII into the easily measurable range. See legend of Fig. 4
for further details. Figure originally published in Victery et al. (5).
demonstrate directly any inhibition of pulmonary
converting enzyme in chronic studies.
Correlation of Changes in the Renin-
Angiotensin System with Blood
Pressure
In two of the experiments previously described
using the in utero exposure protocol, systolic arterial
blood pressure was also measured in the animals (6,7).
These experiments are summarized in the paper by
Victery in this volume (10) and are mentioned here
because they are the only attempts of which we are
aware to correlate lead-induced changes in both the
renin-angiotensin system and arterial blood pressure
in animals. The important findings were that a dose of
100 ppm induced a modest but stable chronic hyper-
tension, whereas a higher dose (500 ppm) and two
lower doses (5 and 25 ppm) failed to do so. As described
previously, the 100 ppm dose that produced hyper-
tension produced a decrease in PRA (but caused no
change in the AII/PRA ratio). Thus, in our studies,
the hypertension induced by lead was low-renin
hypertension. This would suggest that the renin-
angiotensin system is not the cause of the hyperten-
sion; however, recall that these animals (as judged by
the results from their litter-mates shown in Fig. 4)
probably went through a high-renin phase earlier in
life. As in several other models of experimental hyper-
tension, it is possible that the early high-renin phase
was critical for the later development of the hyperten-
sion. More longitudinal studies with and without
blockers of the renin-angiotensin system are required
to testthis hypothesis.
The fact that in the same protocol 100 ppm produced
hypertension whereas the higher dose of 500 ppm did
not suggests, along with other studies (7,10) that there
maybe a biphasic effect oflead on blood pressure, at least
in experimental animals, with hypertension occur-
ring at certain exposure levels but not at higher levels.
One speculative explanation of this phenomenon is
that the decrease in All induced by higher exposures
(the 500 ppm dose, for example, in the experiment just
described) may prevent the development of hyper-
tension, as the presence of normal concentrations ofAII
is known to be permissive for most types of hyper-
tension.
Human Studies
Data from the seven published studies examining
the relationship between lead exposure and PRA in
humans are summarized in Table 2. (As is the case for
the experimental animal work, the results are quite
variable. The two earliest studies (11,12), performed in
the United States, were of 11 subjects, all with frank lead
toxicity (9 from drinking moonshine and 2 from
occupational exposure). PRA was found to be low and
nonresponsive to stimulation by diuretics and salt
deprivation. A third study in the U.S. (13), again of
lead-intoxicated moonshine drinkers, showed similar
results, i.e., depressed PRA, but only in patients with
hyperkalemia; those with normal plasma potassium
concentrations had normal PRA. This contrasts with
the two earlier studies in which the subjects had
depressed PRA despite normokalemia. A fourth study
(14) reporting reduced and unresponsive PRA
following lead exposure involved a single individual
who had suffered marked lead toxicity after cleaning
his garage, which had been formerly used as a
foundry.
In contrast to these studies is a report (15) from the
United Kingdom of normal PRA in 11 subjects exposed
occupationally to high levels of lead. In addition, an
Italian study (16) of 22 occupationally exposed persons
showed considerable variability in PRA; in 14 of the
subjects, PRA was normal (both before and/or after as-
sumption of the upright posture), but was reduced in 5
subjects and elevated in 3. Unfortunately, there was no
statistical evaluation of the group as a whole.
These six studies were of subjects with marked long-
term lead exposure. More recently, a study has been
published (17) of 33 workers with "slight to moderate"
occupational lead exposure for weeks to months (mean
PbB = 35.6 ,ug/dL). The mean PRA for this group was
reported to be "slightly high for a group of normo-
tensive subjects not on sodium restriction," but no
statistics were given. However, as shown in Figure 9,
there was a striking positive exponential correlation
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Table 2. Summary of studies examining relationship between lead exposure and plasma renin activity in humans.a
Exposure
Country, Symptoms of duration/type Status
reference n lead toxicity magnitudeb ofPRAb
United States (16) 33 No Weeks-months Increasedwith
Occupational increasing PbB
Slight-moderate
Italy (15) 8 Yes Years-decades Normal, 4
Occupational Reduced, 3
High level Increased, 1
14 ? Years Normal, 10
Occupational Increased, 2
(?) High level Reduced, 2
United Kingdom (15) 11 Yes Weeks-months Normal
Occupational
High level
United States (12) 33 Yes Years Normal (normalK)
Moonshine Reduced (hyperkalemia)
High level
Switzerland (13) 1 Yes Day(s) Reduced
Cleaning old
foundry
High level
United States (11) 2 Yes Years-decades Reduced
Moonshine, 1
Occupational, 1
High level
United States (10) 9 Yes Years Reduced
Moonshine, 8
Occupational, 1
High level
aAdapted from Sharp et al. (1).
bNumbers refer to the number ofsubjects.
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between PbB and PRA (r2 = 0.58). Positive exponential
relationships were also found between PbB and plasma
Al, plasma angiotensin converting enzyme activity,
and plasma aldosterone concentration; these data in-
dicate that the conversion ofAI toAII was not altered by
lead exposure.
These studies indicate that there is as much vari-
.G ability in the effects of chronic lead exposure on renin
in human beings as in experimental animals. A
.0 ./ . . tentative hypothesis can be suggested: There may be a
12 - tendency for lead-exposed persons to have higher PRA
than normal during the early periods of modest
exposure and have normal or depressed PRA following
* */ more chronic severe exposures. Clearly, longitudinal
. */ * 0.0 studies with carefully delineated exposures are needed.
.0/ * This symposium is concerned with the relationship
. . . - . between lead and blood pressure. In this context, the
following hypotheses involving renin can be made: a)
If exposure to lead increases plasma renin activity in
c I O* 10 1-S 24 25 ~0 certain people, this might be reflected in an increase in
blood pressure as well; b) In contrast, if lead either LEAD lowers plasma renin or does not alter it, then renin
("ov should not be involved in any lead-induced elevation
of blood pressure in humans. A first approach to this
he relationship between blood lead concentration and question is to make simultaneous measurements of
Lnin activity in men occupationally exposed to lead. From blood lead concentration, PRA, and blood pressure.
tal. (16). However, because PRA is so dependent upon sodium
RENIN
(ng/rI/h) ,
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FIGURE 10. Distribution of blood lead concentrations in normotensive
persons and hypertensive persons characterized as high-renin (H),
normal-renin (N), and low-renin (L). Asterisk denotes a subject
who is normotensive but has an elevated renin.
intake, any such study must control for this intake.
Accordingly, we performed, in collaboration with Dr.
Jean E. Sealey (New York Hospital-Cornell Medical
Center), a first preliminary study on a small
population of hypertensive persons in whom so-called
renin-profiling was done, i.e., PRA was characterized
as normal, low, or high on the basis of the expected
PRA at any level of sodium excretion (a marker of
intake) (18). Another compelling reason for studying
this population was that we had just found that the
hypertension produced in rats by lead was a low-renin
hypertension, and we wished to determine whether
patients with low-renin hypertension might have
elevated blood lead concentrations compared to other
hypertensives.
Figure 10 presents the data from this experiment
(unpublished data). Mean blood lead concentrations
for the normal subjects and the entire group of hy-
pertensives were 12.4 ± 0.4 and 14.1 ± 0.8 Hig/dL, which
are not significantly different from each other. How-
ever, there was a progression in the blood lead con-
centrations for the low-, normal-, and high-renin
hypertensives, the means being 12.7 + 1.2, 14.3 ± 1.3,
and 16.8 ± 1.4 gg/dL; the value for the high-renin
group was significantly higher than that for the
normal subjects (p < 0.02). Another way of looking at
the data is that the blood lead concentrations of all 6
persons with high PRA (the 5 persons with high-
renin hypertension and the 1 with high-renin nor-
motension) fell in the upper half of the blood lead
distribution; in contrast, only 16 of the 41 persons with
normal or low PRA fell in this upper half. By chi-
square analysis, this difference in ratios is highly
significant (p < 0.02). These data are consistent with the
hypothesis that lead exposure of modest degree may
increase PRA; the data suggest, however, that if lead
does play a role in human hypertension, it is with
high-renin rather than low-renin hypertension. It
must be emphasized that this is only a preliminary
study with a very small population size.
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